Literature DB >> 20519385

Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.

Elena A Govorkova1, Natalia A Ilyushina, Bindumadhav M Marathe, Jennifer L McClaren, Robert G Webster.   

Abstract

The fitness of oseltamivir-resistant highly pathogenic H5N1 influenza viruses has important clinical implications. We generated recombinant human A/Vietnam/1203/04 (VN; clade 1) and A/Turkey/15/06 (TK; clade 2.2) influenza viruses containing the H274Y neuraminidase (NA) mutation, which confers resistance to NA inhibitors, and compared the fitness levels of the wild-type (WT) and resistant virus pairs in ferrets. The VN-H274Y and VN-WT viruses replicated to similar titers in the upper respiratory tract (URT) and caused comparable disease signs, and none of the animals survived. On days 1 to 3 postinoculation, disease signs caused by oseltamivir-resistant TK-H274Y virus were milder than those caused by TK-WT virus, and all animals survived. We then studied fitness by using a novel approach. We coinoculated ferrets with different ratios of oseltamivir-resistant and -sensitive H5N1 viruses and measured the proportion of clones in day-6 nasal washes that contained the H274Y NA mutation. Although the proportion of VN-H274Y clones increased consistently, that of TK-H274Y virus decreased. Mutations within NA catalytic (R292K) and framework (E119A/K, I222L, H274L, and N294S) sites or near the NA enzyme active site (V116I, I117T/V, Q136H, K150N, and A250T) emerged spontaneously (without drug pressure) in both pairs of viruses. The NA substitutions I254V and E276A could exert a compensatory effect on the fitness of VN-H274Y and TK-H274Y viruses. NA enzymatic function was reduced in both drug-resistant H5N1 viruses. These results show that the H274Y NA mutation affects the fitness of two H5N1 influenza viruses differently. Our novel method of assessing viral fitness accounts for both virus-host interactions and virus-virus interactions within the host.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519385      PMCID: PMC2916532          DOI: 10.1128/JVI.00689-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  Avian influenza A (H5N1) infection in humans.

Authors:  John H Beigel; Jeremy Farrar; Aye Maung Han; Frederick G Hayden; Randy Hyer; Menno D de Jong; Sorasak Lochindarat; Thi Kim Tien Nguyen; Tran Hien Nguyen; Tinh Hien Tran; Angus Nicoll; Sok Touch; Kwok-Yung Yuen
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

2.  Oseltamivir resistance--disabling our influenza defenses.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

3.  Oseltamivir resistance during treatment of influenza A (H5N1) infection.

Authors:  Menno D de Jong; Tan Thanh Tran; Huu Khanh Truong; Minh Hien Vo; Gavin J D Smith; Vinh Chau Nguyen; Van Cam Bach; Tu Qui Phan; Quang Ha Do; Yi Guan; J S Malik Peiris; Tinh Hien Tran; Jeremy Farrar
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

4.  Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor.

Authors:  Shuji Hatakeyama; Yuko Sakai-Tagawa; Maki Kiso; Hideo Goto; Chiharu Kawakami; Keiko Mitamura; Norio Sugaya; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.

Authors:  Hui-Ling Yen; Louise M Herlocher; Erich Hoffmann; Mikhail N Matrosovich; Arnold S Monto; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model.

Authors:  Taronna R Maines; Li-Mei Chen; Yumiko Matsuoka; Hualan Chen; Thomas Rowe; Juan Ortin; Ana Falcón; Tran Hien Nguyen; Le Quynh Mai; Endang R Sedyaningsih; Syahrial Harun; Terrence M Tumpey; Ruben O Donis; Nancy J Cox; Kanta Subbarao; Jacqueline M Katz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

7.  Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.

Authors:  Varough M Deyde; Tiffany G Sheu; A Angelica Trujillo; Margaret Okomo-Adhiambo; Rebecca Garten; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

8.  Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.

Authors:  Yacine Abed; Mariana Baz; Guy Boivin
Journal:  Antivir Ther       Date:  2006

9.  Avian flu: isolation of drug-resistant H5N1 virus.

Authors:  Q Mai Le; Maki Kiso; Kazuhiko Someya; Yuko T Sakai; T Hien Nguyen; Khan H L Nguyen; N Dinh Pham; Ha H Ngyen; Shinya Yamada; Yukiko Muramoto; Taisuke Horimoto; Ayato Takada; Hideo Goto; Takashi Suzuki; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  Nature       Date:  2005-10-20       Impact factor: 49.962

10.  Human disease from influenza A (H5N1), Thailand, 2004.

Authors:  Tawee Chotpitayasunondh; Kumnuan Ungchusak; Wanna Hanshaoworakul; Supamit Chunsuthiwat; Pathom Sawanpanyalert; Rungruen Kijphati; Sorasak Lochindarat; Panida Srisan; Pongsan Suwan; Yutthasak Osotthanakorn; Tanakorn Anantasetagoon; Supornchai Kanjanawasri; Sureeporn Tanupattarachai; Jiranun Weerakul; Ruangsri Chaiwirattana; Monthira Maneerattanaporn; Rapol Poolsavathitikool; Kulkunya Chokephaibulkit; Anucha Apisarnthanarak; Scott F Dowell
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

View more
  22 in total

1.  Diversifying evolution of highly pathogenic H5N1 avian influenza virus in Egypt from 2006 to 2011.

Authors:  E M Abdelwhab; Abdel-Satar Arafa; Jürgen Stech; Christian Grund; Olga Stech; Marcus Graeber-Gerberding; Martin Beer; Mohamed K Hassan; Mona M Aly; Timm C Harder; Hafez M Hafez
Journal:  Virus Genes       Date:  2012-06-05       Impact factor: 2.332

Review 2.  Fitness of neuraminidase inhibitor-resistant influenza A viruses.

Authors:  Tatiana Baranovich; Robert G Webster; Elena A Govorkova
Journal:  Curr Opin Virol       Date:  2011-10-01       Impact factor: 7.090

Review 3.  Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.

Authors:  Elena A Govorkova
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

4.  Targeting a cluster of arginine residues of neuraminidase to avoid oseltamivir resistance in influenza A (H1N1): a theoretical study.

Authors:  L Ramírez-Salinas Gema; L E Tolentino-Lopez; F Martínez-Ramos; I Padilla-Martínez; J García-Machorro; J Correa-Basurto
Journal:  J Mol Model       Date:  2015-01-22       Impact factor: 1.810

5.  Baloxavir Treatment Delays Influenza B Virus Transmission in Ferrets and Results in Limited Generation of Drug-Resistant Variants.

Authors:  Philippe Noriel Q Pascua; Jeremy C Jones; Bindumadhav M Marathe; Patrick Seiler; William V Caufield; Burgess B Freeman; Richard J Webby; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2021-08-23       Impact factor: 5.191

6.  Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.

Authors:  Elena A Govorkova; Tatiana Baranovich; Patrick Seiler; Jianling Armstrong; Andrew Burnham; Yi Guan; Malik Peiris; Richard J Webby; Robert G Webster
Journal:  Antiviral Res       Date:  2013-02-28       Impact factor: 5.970

Review 7.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

8.  Molecular modeling studies demonstrate key mutations that could affect the ligand recognition by influenza AH1N1 neuraminidase.

Authors:  Gema L Ramírez-Salinas; J García-Machorro; Miguel Quiliano; Mirko Zimic; Verónica Briz; Saul Rojas-Hernández; J Correa-Basurto
Journal:  J Mol Model       Date:  2015-10-26       Impact factor: 1.810

9.  A mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal model.

Authors:  James M McCaw; Nimalan Arinaminpathy; Aeron C Hurt; Jodie McVernon; Angela R McLean
Journal:  PLoS Comput Biol       Date:  2011-04-28       Impact factor: 4.475

10.  I222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) viruses.

Authors:  Jennifer L McKimm-Breschkin; Susan Barrett; Muhammad Azhar; Frank Y K Wong; Paul Selleck; Peter G Mohr; James McGrane; Mia Kim
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.